Evidence map›Paper›PMID 37728328›Full record

ArticleeLife2023

Methylglyoxal-derived hydroimidazolone, MG-H1, increases food intake by altering tyramine signaling via the GATA transcription factor ELT-3 in

Muniesh Muthaiyan Shanmugam, Jyotiska Chaudhuri, Durai Sellegounder, Amit Kumar Sahu, Sanjib Guha, Manish Chamoli, Brian Hodge, Neelanjan Bose, Charis Amber, Dominique O Farrera and 4 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Expression ofAnimals : an open access journal from MDPI · 2024
    Article
  5. WormCNN-Assisted Establishment and Analysis of Glycation Stress Models inInternational journal of molecular sciences · 2024
    Article
  6. Article
  7. Anti-Glucotoxicity Effect of PhytoconstituentsInternational journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Muniesh Muthaiyan ShanmugamThe Buck Institute for Research on Aging, Novato, United States.ORCID 0000-0001-8018-2032
Jyotiska ChaudhuriThe Buck Institute for Research on Aging, Novato, United States.
Durai SellegounderThe Buck Institute for Research on Aging, Novato, United States.ORCID 0000-0002-0776-0307
Amit Kumar SahuThe Buck Institute for Research on Aging, Novato, United States.ORCID 0000-0003-0063-5447
Sanjib GuhaThe Buck Institute for Research on Aging, Novato, United States.
Manish ChamoliThe Buck Institute for Research on Aging, Novato, United States.ORCID 0000-0003-0339-7894
Brian HodgeThe Buck Institute for Research on Aging, Novato, United States.
Neelanjan BoseThe Buck Institute for Research on Aging, Novato, United States.
Charis AmberDepartment of Chemistry, University of California, Berkeley, Berkeley, United States.
Dominique O FarreraDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, United States.
Gordon LithgowThe Buck Institute for Research on Aging, Novato, United States.ORCID 0000-0002-8953-3043
Richmond SarpongDepartment of Chemistry, University of California, Berkeley, Berkeley, United States.
James J GalliganDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, United States.ORCID 0000-0002-5612-0680
Pankaj KapahiThe Buck Institute for Research on Aging, Novato, United States.ORCID 0000-0002-5629-4947
Buck Institute for Research on Aging · USUniversity of Arizona · USUniversity of California, Berkeley · US

Funding

SOUTHWEST ENVIRONMENTAL HEALTH SCIENCES CENTERP30ES006694 · NIEHS · UNIVERSITY OF ARIZONA · PI DEAN BILLHEIMER · 1994 to 2026
$36.7M
Training in Environmental Toxicology of Human DiseaseT32ES007091 · NIEHS · UNIVERSITY OF ARIZONA · PI Nathan J Cherrington · 1985 to 2026
$10.7M
Advanced glycation endproducts (AGEs) as metabolic by-products that mediate neurodegeneration.R01AG061165 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI KAPAHI, PANKAJ · 2019 to 2023
$3.3M
Methylglyoxal drives astrocyte senescence to mediate neurodegeneration in Alzheimer's diseaseR01AG068288 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI KAPAHI, PANKAJ · 2020 to 2024
$2.6M
Establishing Glyoxalase 2 as a Viable Target for the Treatment of Disease [Equipment Supplement]R35GM137910 · NIGMS · UNIVERSITY OF ARIZONA · PI GALLIGAN, JAMES J · 2020 to 2024
$2.1M
Glyoxalase 1 and its Role in Metabolic SyndromeR01DK133196 · NIDDK · UNIVERSITY OF ARIZONA · PI James J Galligan · 2023 to 2026
$1.8M
NIA NIH HHS R01 AG061165NIA NIH HHS R01 AG068288NIDDK NIH HHS R01 DK133196NIEHS NIH HHS P30 ES006694NIEHS NIH HHS T32 ES007091NIGMS NIH HHS R35 GM137910NIH HHS R01AG061165NIH HHS R01AG068288NIH HHS R01DK133196NIH HHS R35GM137910
6 · The paper itself

Abstract

The Maillard reaction, a chemical reaction between amino acids and sugars, is exploited to produce flavorful food ubiquitously, from the baking industry to our everyday lives. However, the Maillard reaction also occurs in all cells, from prokaryotes to eukaryotes, forming advanced glycation end-products (AGEs). AGEs are a heterogeneous group of compounds resulting from the irreversible reaction between biomolecules and α-dicarbonyls (α-DCs), including methylglyoxal (MGO), an unavoidable byproduct of anaerobic glycolysis and lipid peroxidation. We previously demonstrated that

Indexed as

Caenorhabditis elegansCaenorhabditis elegans ProteinsAnimalsEatingGATA Transcription FactorsGlycation End Products, AdvancedImidazolesMagnesium OxidePyruvaldehydeSignal TransductionTyramineCaenorhabditis elegans Proteinselt-3 protein, C elegansGATA Transcription FactorsGlycation End Products, AdvancedImidazolesimidazoloneMagnesium OxidePyruvaldehydeTyramineadvanced glycation end-productsC. eleganselt-3feedinggeneticsgenomicsglod-4neurosciencepharyngeal pumpingtyramine

Identifiers

PMID37728328
PMCPMC10611433
OpenAlexW4386878141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.